Clinical Trial Update: Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection [Phase 1, Phase 2]

View source ↗

Summary

This update describes a Phase 1/2 clinical trial evaluating the efficacy, safety, and dose response of a live biotherapeutic product for acute vaginal infection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis
• Vulvovaginal Candidiasis

Drugs mentioned

• Live Biotherapeutic Product

Snippet

Sponsor: NEXBIOME THERAPEUTICS | Conditions: Bacterial Vaginosis, Vulvovaginal Candidiasis | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING